John Koreth, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

John Koreth, Dana-Farber Cancer Institute

Caption

A study by John Koreth shows a novel drug regimen can improve stem cell transplantation outcomes.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.